DAFNA Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

DAFNA Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-34,000	Closed	-$207K	–	81
2016 Q4	$207K	Sell	34,000 -240,563	-88%	-$1.26M	0.18%	62
2016 Q3	$1.51M	Sell	274,563 -45,000	-14%	-$211K	1.05%	34
2016 Q2	$1.21M	Buy	319,563 +25,000	+8%	+$84.7K	0.96%	37
2016 Q1	$813K	Hold	294,563	–	–	0.7%	41
2015 Q4	$1.67M	Sell	294,563 -2,000	-0.7%	-$12.2K	1.49%	20
2015 Q3	$1.57M	Sell	296,563 -21,000	-7%	-$163K	1.56%	19
2015 Q2	$2.64M	Buy	+317,563	New	+$1.54M	2.23%	14

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

DAFNA Capital Management's SGYP Position: Q1 2017 in Review

DAFNA Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2017, closing a stake of 34,000 shares — an estimated $207K sold.

DAFNA Capital Management first reported a position in SGYP in Q2 2015 and held it in 7 quarters. The position peaked at $2.64M in Q2 2015. 164 funds tracked by Wall St. Rank hold SGYP as of Q1 2017.

DAFNA Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2017 after selling out during the quarter.
DAFNA Capital Management sold 34,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2017, an estimated $207K.
DAFNA Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 7 quarters.
DAFNA Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2.64M in Q2 2015.
164 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2017.

Based on DAFNA Capital Management's 13F filing for Q1 2017, filed 15 May 2017.